Abstract 1499: Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients

Abstract Colorectal cancer (CRC) is the third most prevalent cancer type worldwide. Although overall CRC incidence has declined due to improved screening, early-onset CRC (EOCRC) in patients under 50 years old is rapidly increasing globally, including in Korea, unlike the decreasing trend of late-onset CRC (LOCRC). Several studies have attempted to identify EOCRC-specific mutations; however, most were limited to whole-exome sequencing and thus failed to capture CRC-related non-coding variants comprehensively. Moreover, previous mutation-profiling studies relied on the GRCh38 reference genome, a linear and largely European-biased assembly that lacks representation of human genetic diversity, fundamentally limiting the discovery of novel mutations. To address these limitations, we performed whole-genome sequencing (WGS) of paired tumor and matched blood samples from 49 EOCRC and 50 LOCRC Korean patients. Somatic mutations were identified using the graph-based Human Pangenome Reference (Human Pangenome Reference Consortium, released in 2023), which integrates genomic diversity from 49 individuals worldwide. Each sample produced 1.409 billion reads with an average coverage of 37.7×. EOCRC and LOCRC carried an average of 1,673 and 801 somatic mutations in coding regions and 236,610 and 127,616 in non-coding regions—21% and 43% higher than GRCh38-based results. Ten EOCRC-specific coding genes were identified, including LMTK3, GALNT11, and NPHP1, with LMTK3 also reported in a previous Chinese study. In non-coding regions, 32 EOCRC-specific genomic regions were detected, including PRKAG2-GALNTL5, MRGPRF-TPCN2, and ACTRT2-TTC34. Among these, GALNT11, MRGPRF-TPCN2, and ACTRT2-TTC34 contained mutations significantly associated with EOCRC patient survival. Although further expression-level validation is warranted, we propose these three regions as promising genome-level candidates for EOCRC diagnosis and therapy. Additionally, all WGS data have been deposited in the European Genome-phenome Archive (EGA; EGAS50000000544) and are expected to provide a valuable resource for researchers investigating CRC or EOCRC at the genomic level. Citation Format: Jae-Yoon Kim, Soobok Joe, Sunwoo Lee, Yeo-Gyeong Yoon, Jongbum Jeon, Jong Hwan Kim, Jin Ok Yang, Seung-Woo Baek, Jong-Lyul Park, Seon-Kyu Kim, Seon-Young Kim. Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1499.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-1499
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1499: Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients

Jongbum Jeon, J Kim, Soobok Joe, Seon-Kyu Kim et al.
Cancer Research
Cancer Genomics and Diagnostics
article

Abstract 1499: Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients

Jongbum Jeon, J Kim, Soobok Joe, Seon-Kyu Kim, Seung-Woo Baek, J. Daniel Park, Jin Ok Yang, Jae-Yoon Kim, Y D Yoon, Sunwoo Lee, Seon-Young Kim
article en

Abstract

Abstract Colorectal cancer (CRC) is the third most prevalent cancer type worldwide. Although overall CRC incidence has declined due to improved screening, early-onset CRC (EOCRC) in patients under 50 years old is rapidly increasing globally, including in Korea, unlike the decreasing trend of late-onset CRC (LOCRC). Several studies have attempted to identify EOCRC-specific mutations; however, most were limited to whole-exome sequencing and thus failed to capture CRC-related non-coding variants comprehensively. Moreover, previous mutation-profiling studies relied on the GRCh38 reference genome, a linear and largely European-biased assembly that lacks representation of human genetic diversity, fundamentally limiting the discovery of novel mutations. To address these limitations, we performed whole-genome sequencing (WGS) of paired tumor and matched blood samples from 49 EOCRC and 50 LOCRC Korean patients. Somatic mutations were identified using the graph-based Human Pangenome Reference (Human Pangenome Reference Consortium, released in 2023), which integrates genomic diversity from 49 individuals worldwide. Each sample produced 1.409 billion reads with an average coverage of 37.7×. EOCRC and LOCRC carried an average of 1,673 and 801 somatic mutations in coding regions and 236,610 and 127,616 in non-coding regions—21% and 43% higher than GRCh38-based results. Ten EOCRC-specific coding genes were identified, including LMTK3, GALNT11, and NPHP1, with LMTK3 also reported in a previous Chinese study. In non-coding regions, 32 EOCRC-specific genomic regions were detected, including PRKAG2-GALNTL5, MRGPRF-TPCN2, and ACTRT2-TTC34. Among these, GALNT11, MRGPRF-TPCN2, and ACTRT2-TTC34 contained mutations significantly associated with EOCRC patient survival. Although further expression-level validation is warranted, we propose these three regions as promising genome-level candidates for EOCRC diagnosis and therapy. Additionally, all WGS data have been deposited in the European Genome-phenome Archive (EGA; EGAS50000000544) and are expected to provide a valuable resource for researchers investigating CRC or EOCRC at the genomic level. Citation Format: Jae-Yoon Kim, Soobok Joe, Sunwoo Lee, Yeo-Gyeong Yoon, Jongbum Jeon, Jong Hwan Kim, Jin Ok Yang, Seung-Woo Baek, Jong-Lyul Park, Seon-Kyu Kim, Seon-Young Kim. Pangenome-based somatic mutation landscape of early- and late-onset colorectal cancer in 99 Korean patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1499.

Cancer ResearchVol. 86(7_Supplement)
Korea Research Institute of Bioscience and Biotechnology (KR)
Good health and well-being
Openalex Percentile: Top 9%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.